查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
软骨修復/软骨再生市场：依治疗方式、应用、应用部位、地区划分 - 预测至 2028 年
市场调查报告书
商品编码
1397881

软骨修復/软骨再生市场：依治疗方式、应用、应用部位、地区划分 - 预测至 2028 年

Cartilage Repair/Cartilage Regeneration Market by Treatment Modalities (Cell-Based, Non-Cell ), Application, Site, and Region - Global Forecast to 2028
出版日期: | 出版商: MarketsandMarkets | 英文 155 Pages | 订单完成后即时交付

价格
简介目录
调查范围
调查年份 2021-2028
基准年 2022年
预测期 2023-2028
考虑单位 金额（百万美元）
部分 依治疗方式、应用及应用部位
目标区域 北美、欧洲、亚太等地区

全球软骨修復/软骨再生市场规模预计将从 2023 年的 13 亿美元增加到 2028 年的 28 亿美元，预测期内复合年增长率为 17.2%。

软骨细胞移植、生长因子和干细胞等基于细胞的治疗将成为未来几年许多医院基于细胞的研究主题，这主要是由于软骨修復手术数量的增加和骨关节炎病例的增加。并有望加速进展。

从应用来看，由于资金筹措的可近性、研发投资的增加以及新兴国家的成长，预计透明软骨的软骨修復/软骨再生市场将出现最高的成长机会的增加正在推动透明软骨的发展市场。

按地区划分，2022年，北美软骨修復市场的主要参与企业主要集中在美国和加拿大等国家，全膝关节关节重建数量将增加，软骨损伤和受伤治疗的数量将增加软骨修復产品就是用于此目的，使其成为最昂贵的市场。

本报告调查了全球软骨修復/软骨再生市场，并按治疗方式、应用、应用部位、区域和进入市场的公司概况总结了趋势。

目录

第一章简介

第二章调查方法

第三章执行摘要

第 4 章重要考察

第五章市场概况

  • 介绍
  • 市场动态
  • 供应链分析
  • 监管状况
  • 专利分析
  • 管道分析
  • 技术分析

第六章软骨修復/软骨再生市场（依治疗方式）

  • 介绍
  • 基于细胞的软骨修復/软骨再生
  • 非细胞软骨修復/软骨再生

第七章软骨修復/软骨再生市场，依应用领域

  • 介绍
  • 膝关节
  • 髋关节
  • 脚踝/脚
  • 其他的

第八章软骨修復/软骨再生市场，依应用分类

  • 介绍
  • 透明软骨
  • 纤维软骨

第九章软骨修復/软骨再生市场（按地区）

  • 介绍
  • 北美洲
  • 欧洲
  • 亚太地区
  • 其他地区

第10章竞争形势

  • 介绍
  • 收益分析
  • 市场占有率分析
  • 企业评价矩阵
  • 竞争场景

第十一章 公司简介

  • 主要企业
    • SMITH+NEPHEW
    • DEPUY SYNTHES（JOHNSON & JOHNSON）
    • ZIMMER BIOMET HOLDINGS, INC.
    • STRYKER CORPORATION
    • VERICEL CORPORATION
    • B. BRAUN MELSUNGEN AG
    • ANIKA THERAPEUTICS, INC.
    • RTI SURGICAL
    • CONMED CORPORATION
    • ARTHREX INC.
    • REGROW BIOSCIENCES
    • MEDIPOST
  • 其他公司
    • GEISTLICH PHARMA AG
    • ALLOSOURCE
    • ORTHOCELL LTD.
    • CARTIHEAL, INC.
    • REGENTIS BIOMATERIALS
    • LIFENET HEALTH
    • MATRICEL GMBH
    • THERACELL ADVANCED BIOTECHNOLOGY

第十二章附录

简介目录
Product Code: BT 4781

Report Description

Scope of the Report
Years Considered for the Study2021-2028
Base Year2022
Forecast Period2023-2028
Units ConsideredValue (USD) Million
SegmentsTreatment Modality, Application and Application Site
Regions coveredNorth America, Europe, Asia Pacific, and Rest of the World

The global Cartilage Repair/Cartilage Regeneration Market is projected to reach USD 2.8 Billion by 2028 from USD 1.3 Billion in 2023, at a CAGR of 17.2% during the forecast period. Cell-based procedures like chondrocyte transplantation, growth factors, and stem cells are mainly driven by the, rising number of cartilage repair procedures and the increasing number of osteoarthritis cases which is expected to drive the cell-based research and advancement in a number of hospitals in upcoming years.

"The hyaline cartilage segment accounted for the highest market share in the application segment market, by application, during the forecast period."

Based on the application of the segment, the Cartilage Repair/Cartilage Regeneration Market market is categorized into hyaline cartilage and fibrocartilage. Hyaline cartilage is expected to have the highest growth in the market, which is attributed to the availability of the funding and the rising investment in R&D and increasing growth opportunities in emerging economies will drive the hyaline cartilage market.

"The North America segment accounted for the highest market share in Cartilage Repair/Cartilage Regeneration Market Cartilage Repair/Cartilage Regeneration Market, by region, during the forecast period."

Based on the region, the Cartilage Repair/Cartilage Regeneration Market is divided into North America, Europe, Asia Pacific, and Rest of the world. In 2022, North America had the highest market as the key players for the cartilage repair market mainly have the presence in countries like US and Canada and the growing number of knee replacement surgeries and the use of cartilage repair products for the treatment of cartilage damage or injury.

Breakdown of supply-side primary interviews by company type, designation, and region:

  • By Company Type: Tier 1 (30%), Tier 2 (44%), and Tier 3 (26%)
  • By Designation: C-level (30%), Director-level (33%), and Others (37%)
  • By Region: North America (40%), Europe (28%), Asia-Pacific (18%), RoW- (14%),

Prominent companies include Smith+Nephew (UK), DePuy Synthes (Johnson & Johnson) (US), Zimmer Biomet Holdings, Inc. (US), Stryker Corporation (US), Vericel Corporation (US), B. Braun Melsungen AG (US), Anika Therapeutics (US), CONMED Corporation (US), MEDIPOST (South Korea), RTI Surgical (US), Arthrex, Inc. (US), Regrow Biosciences (India), Geistlich Pharma AG (Switzerland), AlloSource (US), Orthocell Ltd, (Australia), Matricel GmbH (Germany), CartiHeal, Inc. (Israel), Regentis Biomaterials (Israel), Theracell Advanced Biotechnology (Greece) and LifeNet Health (US).

Research Coverage

This research report categorizes the Cartilage Repair/Cartilage Regeneration Market which is segmented into products used for Cartilage Repair/Cartilage Regeneration and the application and site of application.

The treatment modality for Cartilage Repair/Cartilage Regeneration is divided into two types: cell-based, i.e., chondrocyte transplantation, growth factors, and stem cells and non-cell-based, i.e., tissue scaffolds and cell-free composites. The Application segments the classised into hyaline cartilage and fibrocartilage. The application site segment is classified as knee, hip, ankle & foot, and other application sites (nose and shoulder), and regional segment is divided into the North America, Europe, Asia Pacific and the Rest of the world. The scope of the report covers detailed information regarding the major factors like market dynamics such as drivers, restraints, challenges, and opportunities that are influencing the growth of the Cartilage Repair/Cartilage Regeneration Market.

A detailed analysis of the key industry players also the companies new launches, developments, mergers and acquisitions associated with the Cartilage Repair/Cartilage Regeneration Market has been covered. Competitive analysis of upcoming startups in the Cartilage Repair/Cartilage Regeneration Market ecosystem is covered in this report.

Key Benefits of Buying the Report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall Cartilage Repair/Cartilage Regeneration Market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

  • Analysis of key drivers (Increasing incidence of osteoarthritis, Increasing research funding and investments and Rising number of sports and accident-related orthopedic injuries), restraints (High cost of cartilage repair surgeries and Unfavorable reimbursement scenario) opportunities (Technological advancements in the cartilage repair market and Development in the field of regenerative medicine and Challenges (Limitation of cartilage-based stem cell products and Need for skill personnel) are influencing the growth of the Cartilage Repair/Cartilage Regeneration Market.
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the Cartilage Repair/Cartilage Regeneration Market.
  • Market Development: Comprehensive information about lucrative markets - the report analyses the Cartilage Repair/Cartilage Regeneration Market across varied regions.
  • Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the Cartilage Repair/Cartilage Regeneration Market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players, among others, in the Cartilage Repair/Cartilage Regeneration Market strategies.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • TABLE 1 INCLUSIONS AND EXCLUSIONS
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED
    • 1.3.3 CURRENCY CONSIDERED
  • 1.4 STAKEHOLDERS
  • 1.5 SUMMARY OF CHANGES
    • 1.5.1 RECESSION IMPACT

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET: RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Secondary sources
    • 2.1.2 PRIMARY DATA
    • FIGURE 2 PRIMARY SOURCES
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key industry insights
      • 2.1.2.3 Breakdown of primary interviews
    • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 APPROACH 1: COMPANY REVENUE ESTIMATION APPROACH
    • FIGURE 4 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION
    • 2.2.2 APPROACH 2: CALCULATING MARKET SIZE FROM NUMBER OF CARTILAGE REPAIR TREATMENT PROCEDURES
    • TABLE 2 REVENUE ESTIMATION APPROACH BY CALCULATING NUMBER OF CARTILAGE REPAIR TREATMENTS PROCEDURES IN US
    • 2.2.3 APPROACH 3: CORPORATE PRESENTATIONS OF COMPANIES AND PRIMARY INTERVIEWS
    • 2.2.4 APPROACH 4: PRIMARY INTERVIEWS
    • 2.2.5 APPROACH 5: FINAL MARKET CALCULATION
    • FIGURE 5 GROWTH FORECAST
    • FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
    • FIGURE 7 TOP-DOWN APPROACH
  • 2.3 MARKET BREAKDOWN & DATA TRIANGULATION
    • FIGURE 8 DATA TRIANGULATION METHODOLOGY
  • 2.4 MARKET SHARE ANALYSIS
  • 2.5 MARKET ASSUMPTIONS
  • 2.6 RISK ASSESSMENT
  • 2.7 LIMITATIONS
  • 2.8 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET: RECESSION IMPACT ANALYSIS

3 EXECUTIVE SUMMARY

    • FIGURE 9 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2023 VS. 2028 (USD MILLION)
    • FIGURE 10 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
    • FIGURE 11 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 12 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET: GEOGRAPHIC SNAPSHOT

4 PREMIUM INSIGHTS

  • 4.1 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET OVERVIEW
    • FIGURE 13 INCREASING INCIDENCE OF OSTEOARTHRITIS TO DRIVE MARKET
  • 4.2 NORTH AMERICA: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION AND COUNTRY, 2022
    • FIGURE 14 HYALINE CARTILAGE HELD LARGEST SHARE IN 2022
  • 4.3 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 15 JAPAN TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 16 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 MARKET DRIVERS
      • 5.2.1.1 Increasing incidence of osteoarthritis
      • 5.2.1.2 Increasing research funding and investments
      • 5.2.1.3 Rising number of sports and accident-related orthopedic injuries
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High cost of cartilage repair surgeries
      • 5.2.2.2 Unfavorable reimbursement scenario
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Technological advancements
      • 5.2.3.2 Developments in regenerative medicine
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Limitations of cartilage-based stem cell products
      • 5.2.4.2 Need for skilled personnel
  • 5.3 SUPPLY CHAIN ANALYSIS
    • FIGURE 17 DISTRIBUTION-KEY STRATEGY PREFERRED BY PROMINENT COMPANIES
  • 5.4 REGULATORY LANDSCAPE
    • 5.4.1 INTRODUCTION
    • 5.4.2 NORTH AMERICA
    • TABLE 3 CLASSIFICATION BASED ON SUBMISSION REQUIRED FOR REGULATORY APPROVAL
    • 5.4.3 EUROPE
    • 5.4.4 ASIA PACIFIC
  • 5.5 PATENT ANALYSIS
    • FIGURE 18 PATENT ANALYSIS FOR CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET
  • 5.6 PIPELINE ANALYSIS
    • 5.6.1 PIPELINE ANALYSIS, BY CLINICAL TRIAL PHASE
    • FIGURE 19 CARTILAGE REPAIR CANDIDATE PRODUCTS IN CLINICAL PHASES ONE TO FOUR
    • TABLE 4 INDICATIVE LIST OF CANDIDATES IN CLINICAL TRIALS
  • 5.7 TECHNOLOGY ANALYSIS

6 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY

  • 6.1 INTRODUCTION
    • TABLE 5 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2021-2028 (USD MILLION)
  • 6.2 CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION
    • TABLE 6 CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 7 CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 8 NORTH AMERICA: CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 9 EUROPE: CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 10 ASIA PACIFIC: CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.2.1 CHONDROCYTE TRANSPLANTATION
      • 6.2.1.1 Cost-effectiveness to support market growth
    • TABLE 11 CHONDROCYTE TRANSPLANTATION MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 12 NORTH AMERICA: CHONDROCYTE TRANSPLANTATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.2.2 GROWTH FACTORS
      • 6.2.2.1 Promising results associated with growth factors to drive market
    • TABLE 13 GROWTH FACTORS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 14 NORTH AMERICA: GROWTH FACTORS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.2.3 STEM CELLS
      • 6.2.3.1 Advancements in stem cell-based tissue engineering to support market growth
    • TABLE 15 STEM CELLS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 16 NORTH AMERICA: STEM CELLS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.3 NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION
    • TABLE 17 NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 18 NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 19 NORTH AMERICA: NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 20 EUROPE: NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 21 ASIA PACIFIC: NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.3.1 TISSUE SCAFFOLDS
      • 6.3.1.1 Benefits of one-step procedure likely to boost market growth
    • TABLE 22 TISSUE SCAFFOLDS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 6.3.2 CELL-FREE COMPOSITES
      • 6.3.2.1 Increasing research to support market growth
    • TABLE 23 CELL-FREE COMPOSITES MARKET, BY REGION, 2021-2028 (USD MILLION)

7 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION SITE

  • 7.1 INTRODUCTION
    • TABLE 24 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2021-2028 (USD MILLION)
  • 7.2 KNEE
    • 7.2.1 INCREASING CASES OF KNEE ARTHROSCOPY TO DRIVE MARKET GROWTH
    • TABLE 25 KNEE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 26 NORTH AMERICA: KNEE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 27 EUROPE: KNEE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 28 ASIA PACIFIC: KNEE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.3 HIP
    • 7.3.1 INCREASING ADOPTION OF MINIMALLY INVASIVE ARTHROSCOPY PROCEDURES TO SUPPORT MARKET GROWTH
    • TABLE 29 HIP CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 30 NORTH AMERICA: HIP CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 31 EUROPE: HIP CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 32 ASIA PACIFIC: HIP CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.4 ANKLE & FOOT
    • 7.4.1 INCREASING SPORTS INJURIES TO DRIVE DEMAND
    • TABLE 33 ANKLE & FOOT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 34 NORTH AMERICA: ANKLE & FOOT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 35 EUROPE: ANKLE & FOOT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.5 OTHER APPLICATION SITES
    • TABLE 36 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET FOR OTHER APPLICATION SITES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 37 NORTH AMERICA: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET FOR OTHER APPLICATION SITES, BY COUNTRY, 2021-2028 (USD MILLION)

8 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
    • TABLE 38 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • 8.2 HYALINE CARTILAGE
    • 8.2.1 HYALINE CARTILAGE SEGMENT TO HOLD LARGER MARKET SHARE
    • TABLE 39 HYALINE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 40 NORTH AMERICA: HYALINE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 41 EUROPE: HYALINE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 42 ASIA PACIFIC: HYALINE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.3 FIBROCARTILAGE
    • 8.3.1 SUPPORT AND STRENGTH ADVANTAGES FOR SURROUNDING STRUCTURES TO DRIVE MARKET
    • TABLE 43 FIBROCARTILAGE REPAIR/REGENERATION MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 44 NORTH AMERICA: FIBROCARTILAGE REPAIR/REGENERATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 45 EUROPE: FIBROCARTILAGE REPAIR/REGENERATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 46 ASIA PACIFIC: FIBROCARTILAGE REPAIR/REGENERATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)

9 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY REGION

  • 9.1 INTRODUCTION
    • TABLE 47 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 9.2 NORTH AMERICA
    • 9.2.1 NORTH AMERICA: RECESSION IMPACT
    • FIGURE 20 NORTH AMERICA: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SNAPSHOT
    • TABLE 48 NORTH AMERICA: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 49 NORTH AMERICA: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2021-2028 (USD MILLION)
    • TABLE 50 NORTH AMERICA: CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 51 NORTH AMERICA: NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 52 NORTH AMERICA: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 53 NORTH AMERICA: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2021-2028 (USD MILLION)
    • 9.2.2 US
      • 9.2.2.1 Increasing incidence of osteoporosis to drive market
    • TABLE 54 US: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2021-2028 (USD MILLION)
    • TABLE 55 US: CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 56 US: NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 57 US: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 58 US: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2021-2028 (USD MILLION)
    • 9.2.3 CANADA
      • 9.2.3.1 Increasing investments in regenerative medicine research to drive market
    • TABLE 59 CANADA: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2021-2028 (USD MILLION)
    • TABLE 60 CANADA: CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 61 CANADA: NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 62 CANADA: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 63 CANADA: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2021-2028 (USD MILLION)
  • 9.3 EUROPE
    • 9.3.1 EUROPE: RECESSION IMPACT
    • TABLE 64 EUROPE: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 65 EUROPE: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2021-2028 (USD MILLION)
    • TABLE 66 EUROPE: CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 67 EUROPE: NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 68 EUROPE: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 69 EUROPE: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2021-2028 (USD MILLION)
    • 9.3.2 GERMANY
      • 9.3.2.1 Strong R&D base and focus on minimally invasive surgeries to support market growth
    • TABLE 70 GERMANY: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2021-2028 (USD MILLION)
    • TABLE 71 GERMANY: CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 72 GERMANY: NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 73 GERMANY: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 74 GERMANY: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2021-2028 (USD MILLION)
    • 9.3.3 UK
      • 9.3.3.1 Rising prevalence of joint diseases to boost demand
    • TABLE 75 UK: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2021-2028 (USD MILLION)
    • TABLE 76 UK: CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 77 UK: NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 78 UK: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 79 UK: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2021-2028 (USD MILLION)
    • 9.3.4 FRANCE
      • 9.3.4.1 Rising degenerative disease and healthcare expenditure to drive market
    • TABLE 80 FRANCE: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2021-2028 (USD MILLION)
    • TABLE 81 FRANCE: CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 82 FRANCE: NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 83 FRANCE: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 84 FRANCE: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2021-2028 (USD MILLION)
    • 9.3.5 REST OF EUROPE
    • TABLE 85 REST OF EUROPE: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2021-2028 (USD MILLION)
    • TABLE 86 REST OF EUROPE: CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 87 REST OF EUROPE: NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 88 REST OF EUROPE: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 89 REST OF EUROPE: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2021-2028 (USD MILLION)
  • 9.4 ASIA PACIFIC
    • 9.4.1 ASIA PACIFIC: RECESSION IMPACT
    • FIGURE 21 ASIA PACIFIC: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET
    • TABLE 90 ASIA PACIFIC: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 91 ASIA PACIFIC: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2021-2028 (USD MILLION)
    • TABLE 92 ASIA PACIFIC: CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 93 ASIA PACIFIC: NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 94 ASIA PACIFIC: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 95 ASIA PACIFIC: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2021-2028 (USD MILLION)
    • 9.4.2 JAPAN
      • 9.4.2.1 Japan to hold largest market share throughout forecast period
    • TABLE 96 JAPAN: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2021-2028 (USD MILLION)
    • TABLE 97 JAPAN: CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 98 JAPAN: NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 99 JAPAN: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 100 JAPAN: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2021-2028 (USD MILLION)
    • 9.4.3 CHINA
      • 9.4.3.1 China to register highest growth in APAC market
    • TABLE 101 CHINA: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2021-2028 (USD MILLION)
    • TABLE 102 CHINA: CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 103 CHINA: NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 104 CHINA: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 105 CHINA: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2021-2028 (USD MILLION)
    • 9.4.4 INDIA
      • 9.4.4.1 Rising number of hospitals and developing healthcare infrastructure to propel market growth
    • TABLE 106 INDIA: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2021-2028 (USD MILLION)
    • TABLE 107 INDIA: CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 108 INDIA: NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 109 INDIA: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 110 INDIA: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2021-2028 (USD MILLION)
    • 9.4.5 REST OF ASIA PACIFIC
    • TABLE 111 REST OF ASIA PACIFIC: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2021-2028 (USD MILLION)
    • TABLE 112 REST OF ASIA PACIFIC: CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 113 REST OF ASIA PACIFIC: NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 114 REST OF ASIA PACIFIC: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 115 REST OF ASIA PACIFIC: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2021-2028 (USD MILLION)
  • 9.5 REST OF THE WORLD
    • 9.5.1 REST OF THE WORLD: RECESSION IMPACT
    • TABLE 116 REST OF THE WORLD: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2021-2028 (USD MILLION)
    • TABLE 117 REST OF THE WORLD: CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 118 REST OF THE WORLD: NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 119 REST OF THE WORLD: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 120 REST OF THE WORLD: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2021-2028 (USD MILLION)

10 COMPETITIVE LANDSCAPE

  • 10.1 INTRODUCTION
  • 10.2 REVENUE ANALYSIS
    • FIGURE 22 TOP FIVE PLAYERS HAVE DOMINATED MARKET IN LAST FIVE YEARS
  • 10.3 MARKET SHARE ANALYSIS
    • FIGURE 23 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET: MARKET SHARE ANALYSIS, 2022
    • TABLE 121 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET: DEGREE OF COMPETITION
  • 10.4 COMPANY EVALUATION MATRIX
    • 10.4.1 STARS
    • 10.4.2 EMERGING LEADERS
    • 10.4.3 PERVASIVE PLAYERS
    • 10.4.4 PARTICIPANTS
    • FIGURE 24 GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET: COMPANY EVALUATION MATRIX, 2022
  • 10.5 COMPETITIVE SCENARIO
    • 10.5.1 PRODUCT APPROVALS
    • TABLE 122 KEY PRODUCT APPROVALS, JANUARY 2020-NOVEMBER 2023
    • 10.5.2 DEALS
    • TABLE 123 KEY DEALS, JANUARY 2020-NOVEMBER 2023
    • 10.5.3 OTHER DEVELOPMENTS
    • TABLE 124 OTHER KEY DEVELOPMENTS, JANUARY 2020-NOVEMBER 2023

11 COMPANY PROFILES

  • 11.1 KEY COMPANIES
  • (Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))**
    • 11.1.1 SMITH+NEPHEW
    • TABLE 125 SMITH+NEPHEW: COMPANY OVERVIEW
    • FIGURE 25 SMITH+NEPHEW: COMPANY SNAPSHOT (2022)
    • 11.1.2 DEPUY SYNTHES (JOHNSON & JOHNSON)
    • TABLE 126 JOHNSON & JOHNSON: COMPANY OVERVIEW
    • FIGURE 26 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2022)
    • 11.1.3 ZIMMER BIOMET HOLDINGS, INC.
    • TABLE 127 ZIMMER BIOMET HOLDINGS, INC.: COMPANY OVERVIEW
    • FIGURE 27 ZIMMER BIOMET HOLDINGS, INC.: COMPANY SNAPSHOT (2022)
    • 11.1.4 STRYKER CORPORATION
    • TABLE 128 STRYKER CORPORATION: COMPANY OVERVIEW
    • FIGURE 28 STRYKER CORPORATION: COMPANY SNAPSHOT (2022)
    • 11.1.5 VERICEL CORPORATION
    • TABLE 129 VERICEL CORPORATION: COMPANY OVERVIEW
    • FIGURE 29 VERICEL CORPORATION: COMPANY SNAPSHOT (2022)
    • 11.1.6 B. BRAUN MELSUNGEN AG
    • TABLE 130 B. BRAUN MELSUNGEN AG: COMPANY OVERVIEW
    • FIGURE 30 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2022)
    • 11.1.7 ANIKA THERAPEUTICS, INC.
    • TABLE 131 ANIKA THERAPEUTICS, INC.: COMPANY OVERVIEW
    • FIGURE 31 ANIKA THERAPEUTICS, INC: COMPANY SNAPSHOT (2022)
    • 11.1.8 RTI SURGICAL
    • TABLE 132 RTI SURGICAL: COMPANY OVERVIEW
    • 11.1.9 CONMED CORPORATION
    • TABLE 133 CONMED CORPORATION.: COMPANY OVERVIEW
    • FIGURE 32 CONMED CORPORATION: COMPANY SNAPSHOT (2022)
    • 11.1.10 ARTHREX INC.
    • TABLE 134 ARTHREX INC.: COMPANY OVERVIEW
    • 11.1.11 REGROW BIOSCIENCES
    • TABLE 135 REGROW BIOSCIENCES: COMPANY OVERVIEW
    • 11.1.12 MEDIPOST
    • TABLE 136 MEDIPOST: COMPANY OVERVIEW
    • FIGURE 33 MEDIPOST: COMPANY SNAPSHOT (2022)
  • 11.2 OTHER PLAYERS
    • 11.2.1 GEISTLICH PHARMA AG
    • 11.2.2 ALLOSOURCE
    • 11.2.3 ORTHOCELL LTD.
    • 11.2.4 CARTIHEAL, INC.
    • 11.2.5 REGENTIS BIOMATERIALS
    • 11.2.6 LIFENET HEALTH
    • 11.2.7 MATRICEL GMBH
    • 11.2.8 THERACELL ADVANCED BIOTECHNOLOGY
  • *Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 CUSTOMIZATION OPTIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS